• Tildrakizumab-asmn is available as an injection or a pre-filled syringe which should be administered by a healthcare provider subcutaneously (just under the skin).
• Pre-filled syringes should be used only once and discarded after that.
• Allergic to tildrakizumab-asmn
• Pregnant and breastfeeding
• With any active infection (e.g., tuberculosis)
• With a low immune system
• Under 18 years of age
• Pre-filled syringes should be used only once and discarded after that.
Dosage & When it is to be taken
• The recommended adult dose is 100 mg to be given at week 0 and at week 4 followed by a dose every 12 weeks after that.When it is not to be taken (Contraindications)
Tildrakizumab-asmn should not be used in patients• Allergic to tildrakizumab-asmn
• Pregnant and breastfeeding
• With any active infection (e.g., tuberculosis)
• With a low immune system
• Under 18 years of age
